Stay updated on Daratumumab for AML/High-Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab for AML/High-Risk MDS Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.6.4 added. A broad set of institutional names, document references, and related metadata were removed from the study record, indicating metadata cleanup rather than changes to the study design or eligibility.
    Difference
    17%
    Check dated 2026-07-25T17:44:47.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision label changed from v3.6.2 to v3.6.3, indicating a minor version update to the page. This update is administrative and does not alter the page's substantive information.
    Difference
    0.1%
    Check dated 2026-07-04T13:18:47.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.0 to v3.6.2. This appears to be a minor metadata update with no substantive changes to the study information or page content.
    Difference
    0.1%
    Check dated 2026-06-27T06:37:20.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now includes new user-help sections (No longer looking for participants; How to Read a Study Record; Common Questions; How to Join a Study) and a new revision tag (Revision: v3.6.0). The older label 'Intervention / Treatment' and the earlier revision tag (Revision: v3.5.5) were removed.
    Difference
    0.6%
    Check dated 2026-06-13T01:20:00.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The revision label on the study record was updated from v3.5.4 to v3.5.5, signaling a new version of the study entry. This reflects a minor update to the record rather than substantive changes to the study design, eligibility criteria, or outcome measures.
    Difference
    0.1%
    Check dated 2026-06-05T22:45:16.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a minor update to the document history. This change does not modify study details or content.
    Difference
    0.1%
    Check dated 2026-05-15T14:30:28.000Z thumbnail image

Stay in the know with updates to Daratumumab for AML/High-Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab for AML/High-Risk MDS Clinical Trial page.